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Saheem Absar, Mujibur Khan*, Kyle Edwards and Jeffrey Neumann

Investigation of synthesis and processing of
cellulose, cellulose acetate and poly(ethylene
oxide) nanofibers incorporating anti-cancer/tumor
drug cis-diammineplatinum (II) dichloride using
electrospinning techniques
Abstract: A model anti-cancer/tumor drug cis-diammineplatinum (II) dichloride (cisplatin) was loaded into
micro- and nanofibers of cellulose, cellulose acetate (CA)
and poly(ethylene oxide) (PEO), using various electrospinning techniques. Single-nozzle electrospinning was
used to fabricate neat fibers of each category. Drug loading in cellulose fibers was performed using single-nozzle
electrospinning. Encapsulation of cisplatin in CA and
PEO-based fibers was performed using coaxial electrospinning. Morphological analysis of the fibers was performed using scanning electron microscopy (SEM) and
energy dispersive X-ray spectroscopy (EDS). The various
categories of fibers exhibited diverse morphological features depending on the material compositions and applied
process parameters. The drug-loaded cellulose nanofibers
showed attached particles on the surface. These particles
were composed of both the polymer and the drug. The CAcisplatin fibers exhibited drug encapsulation within various diverse morphological conformations: hierarchical
structures such as straw-sheaf-shaped particles, dendritic
branched nanofibers and swollen fibers with large beads.
However, in the case of PEO fibers, drug encapsulation
was observed inside repeating dumbbell-shaped structures. Morphological development of the fibers and corresponding mode of drug encapsulation were correlated
with process parameters such as applied voltage, concentrations and relative feed rates of the solutions and conductivities of the solvents.

*Corresponding author: Mujibur Khan, Department of Mechanical
Engineering, Georgia Southern University, 201 COBA Drive
Statesboro, GA 30460-0001, USA,
e-mail: mkhan@georgiasouthern.edu
Saheem Absar and Jeffrey Neumann: Department of Mechanical
Engineering, Georgia Southern University, 201 COBA Drive
Statesboro, GA 30460-0001, USA
Kyle Edwards: Department of Chemistry, Georgia Southern
University, 201 COBA Drive Statesboro, GA 30460-0001, USA

Keywords: drug encapsulation; electrospinning; nanofiber.
DOI 10.1515/polyeng-2015-0057
Received February 16, 2015; accepted March 17, 2015; previously
published online April 18, 2015

1 Introduction
The electrospinning process is a facile method for production of micro- and nanoscale fibers from polymer materials. A charged polymer solution of sufficient viscosity
suspended from a spinneret is drawn under the influence
of high electrostatic forces towards a grounded collector.
Charge repulsion among like charges can overcome the
surface tension of the droplet above a critical voltage. This
effect induces the elongation of the droplet into a characteristic Taylor cone, which subsequently leads to jetting
of the solution into a conical envelope region of complex
flow instabilities. The electrohydrodynamic jetting combined with the flow instabilities promote thinning of the
jet along with solvent evaporation – which ultimately
leads to the formation of solidified nanofibers on the
collector [1–5].
The morphological characteristics of nanofibers can
be tuned or modified by adjusting the electrospinning
parameters. The wide array of adjustable parameters can
be divided into three basic categories – solution, process
and ambient parameters [6]. The solution parameters
consist of the molecular weight of polymer [7, 8], concentration [9–12], viscosity [13, 14] surface tension [15]
and conductivity [16]. The process parameters consist of
voltage [17, 18], flow rate [19], collector type [20, 21] and distance between spinneret tip to collector [22, 23]. Ambient
parameters such as humidity and temperature can also
affect fiber morphology [24, 25]. Some of the parameters
are interrelated to each other such as viscosity, polymer
concentration and molecular weight. The solution
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viscosity and related chain entanglement effects can be
adjusted by choosing a polymer of appropriate molecular
weight or by adjusting the concentration [26, 27].
The prospect of incorporation or functionalization of
bioactive agents such as drugs, proteins, enzymes, antibodies etc., with electrospun nanofibers make them versatile
candidates for development of functional biomaterials
such as drug delivery devices [28, 29], wound dressings [30]
and tissue engineering scaffolds [31]. Attractive properties
of nanofibers such as their extremely high specific surface
area, ultra-high porosity and diverse morphological characteristics are relevant for such applications. For applications in development of drug delivery systems, the large
surface area to volume ratio and high porosity of nanofiber
membranes overcomes the limitation of high drug uptake
associated with other types of drug delivery devices. Additionally, the release mechanism of drugs loaded within
nanofibers can be adjusted by choosing a suitable polymer
and also modifying morphological characteristics of the
nanofibers such as the diameter, porosity and surface features. Such modifications can be achieved by adjusting
the appropriate electrospinning process variables such
as voltage, solution feed rate, ambient conditions, solution viscosity, surface tension and conductivity [32]. Drug
loading into nanofibers can be accomplished by various
methods such as coating, embedding, or encapsulation.
Selection of a proper solvent system is also a critical step for
ensuring stable electrospinning and consistent nanofiber
production. Simple blending of both the drug and polymer
dissolved in a mutually compatible solvent is one of the
methods for preparing solutions for electrospinning. Electrospinning of drug loaded nanofibers was performed by
Tungprapa and coworkers [28] from a solution of cellulose
acetate (CA) in N,N-dimethylacetamide (DMAc) and acetone
blended with various model drugs. Taepaiboon et al. [29]
reported electrospinning of drug loaded poly(vinyl alcohol)
nanofibers using various drugs blended with poly(vinyl
alcohol) in distilled water. Ranganath and Wang [33] fabricated cancer drug paclitaxel loaded poly(D,L lactide-coglycolide) (PLGA) nanofibers by electrospinning a blend
solution of PLGA dissolved in dichloromethane (DCM) and
N,N-dimethylformamide (DMF), and mixed with paclitaxel. Similar methods of electrospinning using solutions
with a mutually compatible solvent for both the drug and
polymer were also reported for fabrication of nanofibers of
poly-ε-caprolactone (PCL)-polyphosphate containing nerve
growth factor protein [34], PCL containing heparin [35] and
PLLA loaded with tetracycline hydrochloride [36]. The drug
and polymer can also be solubilized in separate solvent
systems and mixed together. Kim and coworkers used a
dual solution mixture of PLGA dissolved in DMF along with

an aqueous solution of cefoxitin sodium dissolved in water
to prepare cefoxitin loaded PLGA nanofibers [37]. Kenawy
et al. [38] reported electrospinning of poly(ethylene-covinyl acetate) and poly(lactic acid) solutions in chloroform
mixed with tetracycline HCl solution. Chen et al. [39] fabricated composite nanofibers of PLLA loaded with cisplatin, using dual solutions of PLLA in DCM and cisplatin in
DMF. However, these methods of electrospinning using
drugs blended with polymer solutions renders it difficult
to ascertain complete encapsulation of the drug inside the
nanofibers, since some of the drug particles may be partially embedded or exposed to the surface in the resultant
nanofiber membrane or scaffold. Such approaches are more
suited for applications where a quicker initial release of
drugs from the nanofibers is desired. A drug release profile
with low initial burst release is desirable for sustained and
controlled delivery of drugs from a biodegradable polymer
membrane. To overcome issues of drug encapsulation
with conventional methods, nanofibers of a core-sheath
morphology produced using coaxial electrospinning can
be utilized. Separate solutions of drug and polymer can
be loaded in separate concentric capillaries and coaxially
electrospun to form nanofibers with a core-shell morphology. He and coworkers [40] produced drug-loaded coreshell nanofibers of PLLA using coaxial electrospinning. The
sheath solution consisted of PLLA dissolved in chloroform
and acetone. The core solution consisted of a model drug,
tetracycline HCl dissolved in a mixture of methanol and
chloroform with a small amount of PLLA. Huang et al. [41]
fabricated two types of core-shell PCL nanofibers loaded
with two model drugs by coaxial electrospinning. PCL dissolved in a mixture of chloroform and ethanol was used as
the sheath solution. Two model drugs, resveratrol dissolved
in ethanol and gentamycin sulfate in water, were used as
core solutions. They observed that an increase in drug concentration resulted in a decrease in bead defects when drug
and polymer solutions were miscible (resveratrol-loaded
nanofibers). The opposite effect was observed when the
drug and polymer solutions were immiscible (gentamycin
sulfate loaded nanofibers) [41]. Jiang and coworkers [42]
prepared biodegradable core-shell nanofibers by coaxial
electrospinning of poly-DL-lactic acid (PDLLA) and poly(3hydroxybutyrate) solutions. They reported the flow-rate
of core liquid to have a predominant effect on both outer
and inner fiber diameter. A core-shell structure can shift
the release mechanism to drug diffusion and matrix degradation rather than desorption from the nanofiber surface
[32, 43]. Optimum production of core-shell nanofibers can
be achieved by adjusting parameters such as the relative
feed rates, conductivity and viscosity of the core and shell
solutions. Other factors such as the degree of dissimilarity,
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mutual interfacial interactions and rheological properties
of the core and shell solutions are also important [42, 44].
A modified form of the coaxial electrospinning process for
the preparation of ketoprofen loaded CA nanofibers was
reported by Yu et al [45], where they investigated the effects
of stabilizing the compound electrospinning jet with a nonspinnable sheath solvent. The core solution consisted of CA
hybridized with a drug (ketoprofen). The sheath solution
was a mixture of organic solvents. The core jet is subjected
to electrical drawing for a longer period, facilitating homogeneous core jet solidification and retarding the formation
of surface defects such as wrinkles on the surface of the
nanofibers.
The focus of our work was to achieve encapsulation of
a model drug (cisplatin) inside micro- or nanoscale fibers
produced from various biocompatible polymers. The
core solution used in our electrospinning experiments
consisted of a drug (cisplatin) dissolved in a compatible
organic solvent (DMF), which cannot be electrospun by
itself to form fibers. We investigated the usage of a core
drug solution without hybridizing it with a polymer or
functionalization, to retain the physical state of the drug
without further alteration. Coaxial electrospinning with
a polymer-hybridized drug core and a sheath polymer
would result in the formation of larger fibers.
One of the key processing issues in coaxial electrospinning is the proper selection of core and sheath solvents. However, specialized drugs or pharmaceutical
agents for cancer treatment generally have a very limited
range of compatible solvents. For instance, the anti-cancer
drug cis-diammineplatinum(II) dichloride (cisplatin) is
compatible with a limited number of solvents (DMF, DMA,
DMSO). In some cases, a solvent compatible with the drug
solution can be incompatible with the sheath solvent. As
such, when both the solutions come in contact with each
other at the coaxial spinneret tip, undesirable issues such
as clogging of the spinneret tip due to precipitation of the
polymer can be observed. Interfacial effects at the phase
between the incompatible solutions can lead to unbalanced charge distributions on the compound solution
droplet, resulting in the formation of nonuniform fibers
with several structural defects, resulting in inefficient
drug encapsulation. Therefore, regarding encapsulation
of nonhybridized or non-functionalized drugs within a
polymer matrix, these processing issues can substantially
increase the complexity of coaxial electrospinning.
In this work, we have utilized the approaches of solution blending and coaxial electrospinning to prepare
drug-loaded micro/nanofibers of three different biocompatible polymers: cellulose pulp, CA and poly(ethylene
oxide) (PEO). Neat fibers of each polymer were fabricated
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using single-nozzle electrospinning. For loading of drugs
in the fibers, the following experiments were performed:
(a) Single-nozzle electrospinning of cellulose pulp
dissolved in N-methylmorpholine N-oxide (NMMO.

H2O), combined with a solution of cisplatin dissolved
in DMF.
(b) Coaxial electrospinning using sheath solutions of (i)
CA and (ii) PEO. A solution of cisplatin in DMF was
used as the core solution.
Due to various processing issues involving dissolution and
compatibility with the drug solution, only single-nozzle
mode was used for spinning of drug-loaded cellulose pulp
fibers. Drug encapsulation was performed using coaxial
spinning for CA and PEO solutions due to their stability at
ambient conditions, easier processing steps and compatibility with the drug solution.
Comparative morphological analysis of neat and
drug-loaded fibers of each material system was performed
using scanning electron microscopy (SEM). Elemental
analysis using energy dispersive X-ray spectroscopy (EDS)
was used to verify the presence of cisplatin in the drugloaded fibers. These observations provided insight into
the mode of drug encapsulation in the fibers and assisted
with the correlation of various process parameters with
the morphological development of the various categories
of nanofibers.

2 Materials and methods
The polymers used for fabricating the fibers consisted
of cellulose pulp (DP 1230), CA (Mw 30,000 g/mol, acetyl
content 39.8%) and PEO (Mw 100,000 g/mol). The solvents
used were NMMO.H2O, acetone, DMAc, DMF and deionized
water. The anti-cancer drug used was cis-diammineplatinum (II) dichloride or cisplatin. Other additives consisted
of sodium chloride (NaCl) salt and propyl gallate, an antioxidant. The polymers, solvents and the drug were procured from Sigma Aldrich (St. Louis, MO, USA). Cellulose
pulp was acquired from Georgia-Pacific (GP) cellulose
(Atlanta, GA, USA). Cisplatin was dissolved in DMF at a
concentration of 5 mg/ml. DMF was used as the drug solution. DMF was chosen as the solvent due to its compatibility with cisplatin.
The experiments were performed using a MECC NF-500
electrospinning unit. The unit consists of dual syringe feed
pumps, customizable spinneret attachments and a high
voltage power supply. Neat nanofibers of each category were
prepared by single-nozzle electrospinning (Figure 1A). The
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Figure 1: Electrospinning configurations: (A) single-nozzle, (B) coaxial.

drug-loaded fibers were prepared by coaxial electrospinning (Figure 1B). The specialized coaxial spinneret (Figure 2)
consisted of a 0.6 mm sheath nozzle and a 27-gauge core
nozzle placed concentrically inside the sheath nozzle. The
tip of the core nozzle was extended 0.5 mm below the tip
of the sheath nozzle. The polymer and drug solutions were
fed through the sheath and core nozzles, respectively, using
Teflon tubes connected to individual syringe pumps. The
positive terminal of a high voltage power source was connected to the body of the spinneret. The ground terminal
of the power source was connected to a steel plate collector placed below the spinneret. The steel plate was covered
with an aluminum foil which was used as the fiber deposition substrate. The process parameters, voltage, spinneret
tip-to-collector distance and feed rates, were adjusted by
using the control unit of the NF-500 system.
Morphological analysis of both the neat and drugloaded fibers was performed using a JEOL JSM-7600F scanning electron microscope (JEOL USA, Peabody, MA, USA).
Elemental analysis for determining the fiber compositions
was performed using EDS. One centimeter squares of fiber
samples of each category were cut from the aluminum foil
substrate and sputter-coated with a layer of gold for observation in the SEM. Measurements of dimensions of fibers
and particles were performed using the “ImageJ” (NIH,
Bethesda, MD, USA) application.

3 Results and discussion
The solution compositions for each type of polymer and
the drug used for the electrospinning experiments are

Figure 2: Coaxial spinneret.

shown in Table 1. The relevant electrospinning process
parameters for each category are shown in Table 2.
A solution of cellulose pulp was prepared using NMMO
as the solvent. NMMO powder was first dissolved in 10 ml
of deionized water. Powdered cellulose pulp was then
added to this solution at a loading of 2 wt%. Antioxidant
propyl gallate was added at 1 wt% of cellulose, to prevent
degradation of the cellulose solution during mixing. The
solution was heated at 40–50°C in a sealed flask connected
to a vacuum aspirator. Heating in a vacuum environment
enabled the usage of a lower solution heating temperature
to boil the water content. The reduction of water content
is known to enhance the dissolution of cellulose pulp in
NMMO [46]. A 27-gauge needle was used as the nozzle for
the spinneret. The blend solution of cellulose and cisplatin was not heated while spinning, due to the instability
of cisplatin solutions at elevated temperatures, where it
undergoes a cis-trans isomerization. As such, we avoided
heating the spinneret during single-nozzle spinning to
avoid changing the physical properties of the drug.
Due to complications in effective dissolution of cellulose pulp in NMMO, the resulting solution had a paste-like
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Table 1: Solution compositions used for electrospinning.
Solution

Material

Solvent

Concentration

A
B
C

Cisplatin
Cellulose pulp
Cellulose acetate

5 mg/ml
2 wt%
2 wt%

D

PEO

DMF
NMMO.H2O
Acetone+DMAc (2:1
v/v)
Deionized water+0.9
wt% NaCl

20 wt%

DMAc, dimethylacetamide; DMF, dimethylformamide; NMMO,
N-methylmorpholine N-oxide; PEO, poly(ethylene oxide).

viscosity even at low loading levels (2 wt%) of cellulose pulp.
As such, single-nozzle electrospinning was used for both the
cellulose pulp solutions with and without drug for easier processing. However, the resulting yield of nanofibers was too
low due to high instability in the electrospinning jet, which
mostly led to electrospraying of the solution. The nanofiber
samples were washed with deionized water to extract any
remaining NMMO solvent and to precipitate the cellulose
fibers. The spinning parameters are listed in Table 2.
SEM images of neat cellulose nanofibers showed an
interconnected web of nanofibers of 70–90 nm, as shown
in Figure 3. However, the nanofibers were discontinuous
and showed many surface defects. Electrospinning of the
cellulose-cisplatin solution yielded a very low volume of
production of fibers. SEM images of fibers of this category
did not exhibit any encapsulation of the cisplatin particles
within the fibers. Aggregated particles of cellulose and cisplatin were observed on the surface of the fibers, as shown
in Figure 4A. EDS analysis was performed to determine the
presence of cisplatin in the fibers by observing peaks of
platinum (Pt) and chlorine (Cl) in the spectrum, as shown
in Figure 4B. The weight percentage of characteristic

Figure 3: Scanning electron microscopy (SEM) image of neat cellulose nanofibers.

elements of cellulose (C, O) and cisplatin (Pt, Cl) are also
shown in Figure 4B, and it can be observed that the cisplatin content compared to cellulose is too low. This can
be attributed to the EDS spectrum being based on a single
point scan.
Cellulose has poor solubility in conventional solvents
and results in high viscosity of spinning dopes, due to its
strong intermolecular hydrogen bonding network. Derivatives of cellulose such as CA are easier to process, and
are readily soluble in conventional solvents. The rate of
evaporation of the polymer solvent during spinning can
be optimized by mixing a higher volatility solvent (such
as acetone) with a solvent of lower volatility (such as
DMAc, acetic acid, DMF, water). The solvent characteristics and CA concentration also affect the resultant fiber
morphology [47].
A solvent system of acetone and DMAc at a ratio of
2:1 (v/v) was used for preparing the CA solutions. DMAc
was added to increase the conductivity of the solution
to be used for electrospinning. CA powder was slowly

Table 2: Electrospinning parameters.
Materials

Solution

Feed rate (ml/h)

Cellulose (neat)
Cellulose+cisplatin
CA (neat)
CA+cisplatin

B
B+A
C
Sheath: C
Core: A

0.03–0.1
0.05–0.1
0.5–1.0
0.5 (s);
0.2 (c)
0.3 (s)
0.2 (c)
0.5 (s)
0.2 (c)
0.5
1.0 (s)
0.2–0.6 (c)

PEO (neat)
PEO+cisplatin

D
Sheath: D
Core: A

Voltage
(kV)

Collector
distance (mm)

Relative
humidity (%)

22
28
25
15

100
100
150
150

60
60
35
35

Interconnected nanofibers
Particles attached to fiber surface
Regular nanofibers
Electrosprayed particles

25

210

35

Highly branched fibers

17–20

210

35

Fibers with beads

24
22

120
125

50
44

Regular nanofibers
Nanofibers with repeating beads

c, core; s, sheath; CA, cellulose acetate.
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Figure 4: (A) Formation of aggregates of cellulose and cisplatin particles on the fibers, (B) corresponding energy dispersive X-ray spectroscopy (EDS) spectrum (scanning area shown in inset).

dissolved in the solvent mixture at a concentration of
7.5 wt% under vigorous stirring with a homogenizer. Electrospinning of CA solutions yielded a higher volume of
nanofibers compared to the cellulose pulp solutions. The
resulting neat CA nanofibers were uniform and randomly
distributed with minimal defects, with a size distribution
between 70 nm and 150 nm, as shown in Figure 5.
The coaxial electrospinning experiments for encapsulation of cisplatin in a CA-based sheath yielded three
populations of samples with distinctive morphological
features. The morphological development was affected
by the electrospinning process parameters. The initial
parameters consisted of a voltage of 15 kV, a sheath solution (CA) feed rate of 0.5 ml/h and a core solution (cisplatin) feed rate of 0.2 ml/h. The tip-to-collector distance
was maintained at 150 mm. A stable Taylor cone could
not be obtained at these parameters, which subsequently
resulted in electrospraying of the solution droplet. These
effects resulted in the formation of crystalline straw-sheaf
microstructures of CA conjugated with cisplatin, as shown
in Figure 6. The size distribution of the microstructures

varied widely with sizes as small as 2–10 μm, and larger
structures of 30–60 μm in length. A magnified SEM image
of the straw-sheaf-like structure is shown in Figure 7A.
The hierarchical microstructure is composed of a bundle
of thin filaments clustered together with a narrow contraction in the middle. EDS analysis indicated the cisplatin
content in the structure through the presence of Pt and Cl
peaks in the EDS spectrum, as shown in Figure 7B. The cisplatin particles were uniformly distributed on the structure, as shown by the EDS map of the Pt distribution given
in the inset of Figure 7B.
The process parameters were subsequently adjusted
to a higher voltage of 25 kV, while maintaining the solution feed rates of the sheath (CA) at 0.3 ml/h and core
(cisplatin) at 0.2 ml/h. The tip-to-collector distance was
kept at 210 mm. The compound Taylor cone exhibited a
different mode of behavior upon application of a higher
voltage. Extensive jet splaying and whipping instabilities
were observed at the compound solution droplet. This
set of parameters generated continuous nanofibers with
repeating dendritic branched features aligned uniformly

Figure 5: Scanning electron microscopy (SEM) image of neat cellulose acetate nanofibers.

Figure 6: Scanning electron microscopy (SEM) image of electrosprayed cellulose acetate (CA)-cisplatin particles.
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Figure 7: (A) Magnified scanning electron microscopy (SEM) image of the cellulose acetate (CA)-cisplatin straw-sheaf microstructure,
(B) corresponding energy dispersive X-ray spectroscopy (EDS) spectrum (scanning area and Pt distribution map shown in inset).

on the deposition area, as shown in Figure 8. Each of
the hierarchical structures are composed of periodically
spaced branches of varying sizes of 7–20 μm in length,
protruding from a long continuous main stem of 0.7–1 μm

Figure 8: Scanning electron microscopy (SEM) image of hierarchically branched microfibers of cellulose acetate (CA) loaded with
cisplatin.

in diameter. The sub-branches are further subdivided into
more branches follwing a pattern similar to the aforementioned configuration. The main stems are arranged unidirectionally in parallel and are spaced apart at distances
varying from 17 μm to 25 μm. A magnified SEM image of
the branching pattern is shown in Figure 9A. The hierarchical structure is evident even at the nanoscale. The
stems diameters vary from 75 nm to 100 nm, with protruding branches as small as 130–150 nm and larger branches
of 300–700 nm in length. The diameters of the branches
vary between 60 nm and 90 nm. EDS scan of an area of the
branched structure indicated the presence of cisplatin, as
shown in Figure 9B.
The formation of these highly branched hierarchical
structures indicates the occurrence of branching effects
both during drawing of the electrospinning jet and solidification of the fibers on the collector. The combined effect
of extremely high electrical stresses and surface tension
can generate complex static undulations on the surface
of a conducting fluid jet. Such undulating sites on the jet
surface can influence the formation of flow instabilities

Figure 9: (A) Magnified scanning electron microscopy (SEM) image of sub-branches of cellulose acetate (CA)-cisplatin fibers, (B) corresponding energy dispersive X-ray spectroscopy (EDS) spectrum (scanning area and Pt distribution map shown in inset).
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leading to the emanation of lateral branches from the
primary jet [48]. As shown by Holzmeister et al. [49], formation of reguarly spaced barbs on nanofibers can be
generated due to the competition between slow charge
relaxation and the electrically driven surface instabilities
on the electrospinning jet. When the disparity of the slow
charge relaxation compared to the rate of growth of the
secondary instabilities becomes more pronounced, the
barbs can transform to full scale long branches. Factors
leading to such disparities are influenced by the polymer
solution conductivity and viscoelasticity. Addition of
solvents with high dielectric constants such as DMF and
DMAc into spinning solutions can induce extensive jet
splaying during electrospinning. Hsu and Shivkumar [50]
observed that addition of DMF in solutions of PCL in DCM
caused initiation of jet splaying into multiple mini-jets
almost immediately below the spinneret or needle tip. The
jet-splitting effects also affected the resultant fiber morphology, by generating multimodal size distributions in
the produced fibers.
The fractal-like nature of the branching exhibited
in Figure 9A also suggests the ocurrence of a dielectric
breakdown in the fibers during solidification of the electrospinning jet on the collector plate. These conductive
paths resemble tree-like branched or dendritic features,
also known as Lichtenberg figures [51]. The formation
of the self-similar or fractal-like nature of the resultant
structure can be explained by the process of “diffusionlimited aggregation” [52]. In this process, particles undergoing diffusion in a medium aggregate around seed
particles which act as nucleation centers. The repetitive
process results in a highly branched cluster of particles,
since the arriving particles are more likely to be attached
to the tips of outer branches than maneuver towards the
inner regions. New branches are also generated from each
tip site, which result in the formation of a self-similar
branched fractal stucture. Dawar and Chandra [53, 54]
showed the effect of an external electric field in diffusionlimited aggregation-influenced branched fractal formation in conductive polymer electrolytes dispersed with
Al2O3 seed particles. The electric field allows the formation
of ordered branched structures aligned along the electric
field direction. Branched structure growth in this case is
governed by a complex interplay of diffusion, migration
and electroconvection.
In our experiment, when subjected to a substantially
higher voltage of 25 kV, higher drawing forces on the compound droplet ejected from the spinneret introduced a
larger volume of the core cisplatin solution with the electrospinning jet. Upon contact with the grounded collector, a rapid discharge of excess charges in the compound

solution jet was initiated due to dielectric breakdown,
resulting in the creation of electrically conductive paths
along the surface of the fibers. Seed particles of cisplatin
in the solution acted as nucleation centers for aggregation
of more cisplatin particles as branched clusters. The EDS
scanning map of the branched fibers shown in Figure 9B
shows the elemental distribution of Pt, which supports
the model of branched cluster formation of cisplatin particles. Finally, evaporation of the solvent yielded an ordered
arrangement of highly branched CA fibers on the collector.
Further adjustment of the parameters generated
a third population of fibers containing large beads, as
shown in Figure 10. The voltage was varied between 17 kV
and 20 kV and the sheath and core solution feed rates
were maintained at 0.5 ml/h and 0.2 ml/h, respectively.
The fibers ranged in size from 500 nm to 1 μm, with larger
fibers between 2 μm and 6 μm. The larger fibers seem to
be fused and interconnected with several adjacent fibers
along their length.
A large bead present in the observed sample was perforated by increasing the SEM acceleration voltage and
focusing the high intensity electron beam of the SEM at
a single point on it. The subsequent degradation of the
CA sheath of the bead exposed an inner layer of cisplatin
particles dispersed within the interior of the solid bead,
as shown in Figure 11A. An EDS scan of the bead site was
performed which indicated encapsulation of the cisplatin
particles within a layer of CA, shown in Figure 11B.
To summarize our observations regarding the morphological evolution of structures from the coaxial electrospinning of CA and cisplatin solutions, the parameters
(applied voltage, sheath flow rate, tip-to-collector distance) were adjusted to enable the proper formation of
fibers from the electrospinning jet, while also achieving

Figure 10: Swollen beads on cellulose acetate fibers loaded with
cisplatin.
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Figure 11: (A) Cisplatin particles dispersed inside a perforated bead of cellulose acetate (CA), (B) corresponding energy dispersive X-ray
spectroscopy (EDS) spectrum (scanning area shown in inset).

suitable encapsulation of the drug solution inside the
sheath solution. The initial set of parameters (15 kV,
25 kV) provided us the indication of the behavior of the
compound solution during coaxial spinning at the lower
and upper bounds, and their effects on sample fiber morphology. For example, at 15 kV the compound solution
led to electrospraying, which formed drug-loaded microparticles. At 25 kV, the solution formed highly branched
drug-loaded fibers. These observations indicate that at
lower voltages, viscoelastic effects overcome the electrical stresses, while at extremely high voltages the electrical
stresses play a much more dominant role in determining
the fiber morphology. The population of fibers observed
in Figure 10 was formed at a moderate voltage range of
17–20 kV. At this set of parameters, the spinning jet was
more stable and continuous, leading to the formation of
randomly distributed beaded drug-loaded fibers.
For electrospinning experiments of PEO nanofibers,
a 20 wt% PEO solution in deionized water was prepared
under constant stirring with a magnetic stirrer. NaCl
(0.9 wt%) was added to the deionized water to increase
the solution conductivity. Neat PEO nanofibers were produced using single-nozzle electrospinning (parameters
listed in Table 2). The resultant nanofibers were randomly
distributed and showed uniform surface features. An SEM
image of the neat PEO nanofibers is shown in Figure 12.
The diameters of the nanofibers were widely distributed
between 80 nm and 200 nm.
Coaxial electrospinning was subsequently performed
to encapsulate cisplatin inside PEO nanofibers. The
feed rate of the sheath was maintained at 1.0 ml/h, and
the core solution feed rate was varied between 0.2 ml/h
and 0.6 ml/h. Other process paramaters (voltage, collector distance, relative humidity) are listed in Table 2. The
drug-loaded PEO nanofibers displayed the formation of
sporadically spaced beaded structures along the length

Figure 12: Scanning electron microscopy (SEM) image of neat
poly(ethylene oxide) (PEO) nanofibers.

of the fibers, as shown in Figure 13. The dumbbell-shaped
features suggest the encapsulation of drug particles inside
the PEO shell layer. The beads vary between 140 nm and
170 nm and the connecting fibers vary between 45 nm
and 70 nm in size. The magnified SEM image of Figure 14
shows clear phase separation between the core and sheath
layers. The sheath layer thickness ranged between 8 nm
and 25 nm, while the core layer thickness ranged between
43 nm and 108 nm in the beads, and 30 nm and 40 nm in
the connecting nanofibers between the beads.
Core-sheath fiber formation is affected by the difference in conductivity between the sheath and core
solutions. The core solution contains DMF, which is a
polyelectrolytic solvent with higher conductivity than
the sheath solution containing water. Compared to the
sheath solution, the core solution experiences higher
charge buildup, leading to increased extensional forces
in the core solution due to surface charge repulsion.
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Figure 13: Drug-loaded poly(ethylene oxide) (PEO) nanofibers
showing formation of repeating beads containing cisplatin.

Figure 15: Formation of beaded structures due to jet breakup
effects in core solution during coaxial electrospinning.

Figure 14: Magnified scanning electron microscopy (SEM) image
of cisplatin-loaded poly(ethylene oxide) (PEO) nanofibers showing
formation of distinct core and sheath layers.

Additionally, the viscosity and surface tension of the core
solution are much lower than that of the shell solution,
which render it incapable of forming fibers. A lower viscosity core solution will thus initiate jet breakup during
electrospinning [55]. For fiber formation with continuous
core-shell structure using coaxial electrospinning, the core
solution should be confined within the sheath through the
effect of viscous drag. If the core solution is significantly
lower in viscosity than the sheath, jet breakup of the core
solution will occur. This effect will cause the core solution
to be pulled intermittently inside the sheath. The sheath
will then spread along its length and migrate towards the
droplet to hold it inside a beaded structure. A schematic of
this process is shown in Figure 15. As such, the reduction
of size of the connecting nanofibers (15–20 nm) between

the droplets compared to the neat PEO fibers (40–160 nm)
can be attributed to the effects of droplet migration. Díaz
et al. [56] described encapsulation of hydrophobic liquids
in hydrophilic polymer nanofibers using coaxial electrospinning. They obtained nanofibers which encapsulated
oil within periodically spaced beads. The inner oil did not
form a continuous core, but a string of discrete pockets.
The inner jet (oil) of the compound Taylor cone being a
Newtonian liquid, underwent varicose break-up at a
faster rate than the solidification of the outer sheath, even
though the small interfacial tension and the high viscosity of the outer liquid slowed down the break-up process.
They found that the bead-to-bead distance and fiber
diameter may be controlled by the outer liquid flow rate,
while the bead diameter may be controlled by adjusting
the inner liquid flow rate.

4 Conclusion
Micro- and nanoscale fibers of cellulose, CA and PEO were
fabricated using electrospinning. A model anti-cancer/
tumor drug, cis-diammineplatinum (II) dichloride (cisplatin) was encapsulated in the fibers using coaxial electrospinning. Morphological analysis of the various categories
of fibers was performed using SEM and EDS. The fibers
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exhibited diverse morphological features depending on
the material compositions and process parameters. Drugloaded cellulose nanofibers showed particles composed
of both cellulose and cisplatin attached to the surface.
The CA-cisplatin fibers exhibited drug encapsulation
within various diverse morphological configurations
composed of swollen fibers and hierarchical structures
of straw-sheaf like microparticles and branched fibers.
Nanofibers of PEO showed encapsulation of drug inside
repeating dumbbell-shaped structures formed along the
length of the nanofibers. The morphological characteristics and manner of drug encapsulation were correlated
with process parameters such as applied voltage, concentrations and relative feed rates of the solutions and conductivities of the solvents.
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